Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
319.46B | 303.03B | 279.31B | 245.42B | 266.75B | 255.94B | Gross Profit |
109.33B | 101.96B | 90.20B | 83.95B | 117.81B | 115.09B | EBIT |
28.80B | 27.16B | 22.23B | 25.14B | 27.06B | 27.66B | EBITDA |
41.38B | 43.18B | 34.83B | 37.85B | 37.29B | 35.00B | Net Income Common Stockholders |
21.07B | 19.89B | 14.77B | 18.05B | 17.68B | 17.54B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.24B | 44.30B | 32.17B | 59.00B | 73.47B | 73.56B | Total Assets |
102.11B | 292.16B | 239.09B | 236.60B | 238.98B | 214.97B | Total Debt |
79.00M | 27.04B | 1.85B | 1.98B | 6.56B | 1.33B | Net Debt |
-11.16B | -17.26B | -30.32B | -33.02B | -28.01B | -41.58B | Total Liabilities |
24.53B | 91.07B | 56.41B | 53.14B | 56.24B | 45.34B | Stockholders Equity |
74.33B | 191.75B | 174.11B | 175.38B | 175.37B | 163.24B |
Cash Flow | Free Cash Flow | ||||
-4.50B | -6.84B | -7.41B | 8.81B | 19.11B | 31.45B | Operating Cash Flow |
29.63B | 24.35B | 19.31B | 22.33B | 30.45B | 40.45B | Investing Cash Flow |
-37.80B | -35.31B | -20.33B | 3.64B | -32.07B | -13.46B | Financing Cash Flow |
7.38B | 16.85B | -20.00B | -25.17B | -7.63B | -6.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$2.47B | 17.26 | 10.34% | 2.01% | ― | ― | ||
65 Neutral | $8.89B | 15.01 | 4.75% | 203.76% | 3.54% | -2.49% | |
€2.82B | 15.97 | 9.19% | 1.96% | ― | ― | ||
€1.85B | 52.41 | 2.04% | 1.96% | ― | ― | ||
70 Outperform | ¥77.69B | 14.34 | 1.55% | 8.09% | 140.01% | ||
70 Outperform | ¥50.46B | 19.48 | 1.16% | 8.31% | 17.33% | ||
66 Neutral | ¥260.53B | 16.54 | 1.94% | 25.63% | -24.35% |